Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread
Conditions: Metastatic Pancreatic Adenocarcinoma; Stage IV Pancreatic Cancer AJCC v8 Interventions: Drug: Fluorouracil; Drug: Gemcitabine; Drug: Gemcitabine Hydrochloride; Drug: Leucovorin; Drug: Leucovorin Calcium; Drug: Liposomal Irinotecan; Drug: Nab-paclitaxel; Other: Quality-of-Life Assessment; Other: Questionnaire Administration Sponsors: ECOG-ACRIN Cancer Research Group; National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adenocarcinoma | Calcium | Cancer | Cancer & Oncology | Pancreas | Pancreatic Cancer | Research